knowledge -WSS

knowledge

author：fashion 2025-08-23 08:57:12 - browse：88

The back of three medicine containers, a bottle in between two boxes, all showing labels — coverage from STAT — Adobe

After a drug enters the market, it’s up to Food and Drug Administration regulators to ensure its continued safety and efficacy. A recent New York Times story suggests that, in the case of the popular asthma drug Singulair, the FDA fell short — both because the agency delayed action for years on reports from patient advocates and independent groups that the drug could cause suicidal thoughts, and because when it did add a warning label about its potential side effects in 2020, clinicians and patients still weren’t always aware of the risks.

Experts say that the Singulair incident highlights a flawed system, both in the U.S. and globally, for monitoring adverse reactions after a drug is on the market — one that will require extensive changes to address.

“The question is, how safe do you want to be?” said Ameet Sarpatwari, the assistant director of the Program on Regulation, Therapeutics, and Law at Brigham and Women’s Hospital. Ideally, he said, the FDA should be able to both stay on top of safety concerns and avoid unnecessarily restricting access to drugs. “Are we at the right balance? I think there are definitely situations for many drugs where you can say, no, we’re not really at the right balance, and the FDA should be taking a more aggressive stance in promoting patient safety.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： Ed Silverman on new gene therapies, biosimilars, coffee, and more

focus

WSS

Obesity drugs seen as possible treatment for liver disease MASH

The Readout: Abbvie and Humira, CRISPR in utero, Annovis Bio

PBM reform efforts get punted in Congress

Belarusian journalist sentenced to 4 years in prison as crackdown continues

The Harvard botanist who searched for psychedelics in the Amazon

Federal board approves $12.7 billion budget for Puerto Rico as island shakes off bankruptcy

knowledge

knowledge

hotspot

Drug repurposing or repositioning? The language matters

Alabama IVF ruling threatens families facing fatal genetic disease

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

The simple reason for the increase in autism diagnosis

The cancer drug shortage isn’t new — and neither are the solutions

Thousands protest in Iraq for a second day over burning of Quran in Sweden

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Here's how to stay safe from wildfire smoke amid reduced air quality

Affirmative action in medical school literally saved lives

Alabama frozen embryo ruling has major implications for IVF clinics

Wikipedia

Dario to buy mental health app maker Twill in cash and stock deal

Anger, defiance, fear over Supreme Court decision to block student loan forgiveness

Obesity drugs seen as possible treatment for liver disease MASH

Why do we get seasonal allergies?

Ed Silverman on new gene therapies, biosimilars, coffee, and more

Readout Newsletter: Alnylam, Celldex, Roche, Zealand Pharma

focus

focus

leisure time

focus